At 17.7% CAGR, the Europe Whole Slide Imaging Market is projected to be worth US$ 405.60 million by 2028, says Business Market Insights   

According to Business Market Insights’ research, the Europe whole slide imaging market was valued at US$ 152.37 million in 2022 and is expected to reach US$ 405.60 million by 2028, registering an annual growth rate of 17.7% from 2022 to 2028. Boosting technological advancements in whole slide imaging and raising adoption of digital pathology.                

The concept of whole slide imaging emerged in the late 1990s. In initial phase, the system utilized microscope and computer combination to capture composite slide image. However, the system required considerable amount of time for image acquisition. In order to overcome this limitation, technology companies used automated algorithms and high-speed systems to boost the speed of image acquisition. This technological development extends the area of application for whole slide imaging. The new guidelines will ensure patients get their pathologic diagnosis quickly with the same quality test results and thereby possibly receive treatment sooner. Continual advancements in computational algorithms and image capturing technologies are making a constructive impact on the development of whole slide imaging technologies. Improvements in this technology are leading to a better throughput, error reduction, quick and efficient image capturing, image archiving, and image sharing. For instance, in December 2019, Molecular Machines & Industries (MMI) launched MMI CellScan, an advanced whole slide imaging technology for digital pathology. The company introduced this system at Digital Pathology Congress, the UK. As per the company, this system enables quick scan and magnification with different imaging modes. Additionally, in March 2019, NanoString announced launch of GeoMx Digital Spatial Profiler, a next generation whole slide imaging technology for detailed spatial profiling of nucleic acid molecules. This clearance enables Dynamyx customers to use whole slide images (WSIs) for primary diagnosis instead of traditional glass slides, yielding powerful benefits to pathologists and laboratories. Furthermore, in October 2019, Olympus Corporation announced launch of its SLIDEVIEW VS200, an advanced slide scanner for high-resolution image acquisition. The equipment is capable of high-speed data acquisition and image processing of tissue samples as well as single cell. Such technological developments are estimated to drive the adoption of whole slide imaging systems, which would eventually boost the market growth during the forecast period.  

On the contrary, excessive cost associated with installation and maintenance of whole slide imaging. 

• Based on type, the Europe whole slide imaging market is segmented into hardware, software, and services. The hardware segment held 44.2% market share in 2022, amassing US$ 67.35 million. It is projected to garner US$ 185.04 million by 2028 to expand at 18.3% CAGR during 2022–2028.
• Based on application, the Europe whole slide imaging market is categorized into telepathology, cytopathology, immunohistochemistry, and hematopathology. The telepathology segment held 42.4% market share in 2022, amassing US$ 64.54 million. It is projected to garner US$ 174.02 million by 2028 to expand at 18.0% CAGR during 2022–2028.
• Based on end user, the Europe whole slide imaging market is segmented into academic research institutes, hospitals, pharmaceutical and biopharmaceutical companies, and laboratories. The academic research institutes segment held 37.2% market share in 2022, amassing US$ 56.76 million. It is projected to garner US$ 152.79 million by 2028 to expand at 17.9% CAGR during 2022–2028
• Based on country, the Europe whole slide imaging market has been segmented into Germany, France, United Kingdom, Italy, Spain, and Rest of Europe.  Our regional analysis states that Germany captured 22.9% market share in 2022. It was assessed at US$ 34.92 million in 2022 and is likely to hit US$ 96.41 million by 2028, exhibiting a CAGR of 18.4% during the forecast period.  

Key players dominating the Europe whole slide imaging market are 3DHISTECH Ltd.; Hamamatsu Photonics K.K.; Indica Labs; Inspirata Inc.; Leica Biosystems Nussloch GmbH (Danaher); Nikon Corporation; Olympus Corporation; Visiopharm A/S; Akoya Biosciences, Inc.; and Koninklijke Philips N.V. among others.

In August 2021, while microscope slides allow you to see only one section of reality, 3DViewTM is a tool that can reconstruct the original tissue from its serial sections. The 3D image can then be rotated, zoomed into and “sliced” arbitrarily according to user needs.

• In September 2020, Akoya Biosciences, Inc., announced the availability of Proxima, to incorporate rapid image acquisition and secure data sharing in the cloud with instant access from anywhere for geographically distributed and remote teams, including those working from home during the COVID-19 pandemic.  

Contact Us
Phone: +16467917070
Email Id: sales@businessmarketinsights.com